Gastroenterology
Volume 139, Issue 3 , Pages 763-769 , September 2010

Morbidity and Mortality Among Older Individuals With Undiagnosed Celiac Disease

  • Jonathan D. Godfrey

      Affiliations

    • Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota
    • ,
  • Tricia L. Brantner

      Affiliations

    • Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota
    • ,
  • Waleed Brinjikji

      Affiliations

    • Mayo Medical School, Mayo Clinic, Rochester, Minnesota
    • ,
  • Kevin N. Christensen

      Affiliations

    • Mayo Medical School, Mayo Clinic, Rochester, Minnesota
    • ,
  • Deanna L. Brogan

      Affiliations

    • Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota
    • ,
  • Carol T. Van Dyke

      Affiliations

    • Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota
    • ,
  • Brian D. Lahr

      Affiliations

    • Division of Biomedical Informatics and Statistics, Mayo Clinic, Rochester, Minnesota
    • ,
  • Joseph J. Larson

      Affiliations

    • Division of Biomedical Informatics and Statistics, Mayo Clinic, Rochester, Minnesota
    • ,
  • Alberto Rubio–Tapia

      Affiliations

    • Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota
    • ,
  • L. Joseph Melton III

      Affiliations

    • Division of Epidemiology, Mayo Clinic, Rochester, Minnesota
    • ,
  • Alan R. Zinsmeister

      Affiliations

    • Division of Biomedical Informatics and Statistics, Mayo Clinic, Rochester, Minnesota
    • ,
  • Robert A. Kyle

      Affiliations

    • Division of Hematology, Mayo Clinic, Rochester, Minnesota
    • ,
  • Joseph A. Murray

      Affiliations

    • Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota
    • Corresponding Author InformationReprint requests Address requests for reprints to: Joseph A. Murray, MD, Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street Southwest, Rochester, Minnesota 55905. fax: (507) 255-6318

Received 4 December 2009 ,Accepted 10 May 2010.

References 

  1. Cook HB, Burt MJ, Collett JA, et al. Adult coeliac disease: prevalence and clinical significance. J Gastroenterol Hepatol. 2000;15:1032–1036
  2. West J, Logan RF, Hill PG, et al. Seroprevalence, correlates, and characteristics of undetected coeliac disease in England. Gut. 2003;52:960–965
  3. Lohi S, Mustalahti K, Kaukinen K, et al. Increasing prevalence of coeliac disease over time. Aliment Pharmacol Ther. 2007;26:1217–1225
  4. Corrao G, Corazza GR, Bagnardi V, et al. Mortality in patients with coeliac disease and their relatives: a cohort study. Lancet. 2001;358:356–361
  5. West J, Logan RF, Smith CJ, et al. Malignancy and mortality in people with coeliac disease: population based cohort study. BMJ. 2004;329:716–719
  6. Solaymani-Dodaran M, West J, Logan RF. Long-term mortality in people with celiac disease diagnosed in childhood compared with adulthood: a population-based cohort study. Am J Gastroenterol. 2007;102:864–870
  7. Green PH, Fleischauer AT, Bhagat G, et al. Risk of malignancy in patients with celiac disease. Am J Med. 2003;115:191–195
  8. Viljamaa M, Kaukinen K, Pukkala E, et al. Malignancies and mortality in patients with coeliac disease and dermatitis herpetiformis: 30-year population-based study. Dig Liver Dis. 2006;38:374–380
  9. Collin P, Reunala T, Pukkala E, et al. Coeliac disease–associated disorders and survival. Gut. 1994;35:1215–1218
  10. Murray JA, Watson T, Clearman B, et al. Effect of a gluten-free diet on gastrointestinal symptoms in celiac disease. Am J Clin Nutr. 2004;79:669–673
  11. Cronin CC, Jackson LM, Feighery C, et al. Coeliac disease and epilepsy. QJM. 1998;91:303–308
  12. Hadjivassiliou M, Chattopadhyay AK, Davies-Jones GA, et al. Neuromuscular disorder as a presenting feature of coeliac disease. J Neurol Neurosurg Psychiatry. 1997;63:770–775
  13. Hu WT, Murray JA, Greenaway MC, et al. Cognitive impairment and celiac disease. Arch Neurol. 2006;63:1440–1446
  14. Lubrano E, Ciacci C, Ames PR, et al. The arthritis of coeliac disease: prevalence and pattern in 200 adult patients. Br J Rheumatol. 1996;35:1314–1318
  15. Not T, Tommasini A, Tonini G, et al. Undiagnosed coeliac disease and risk of autoimmune disorders in subjects with type I diabetes mellitus. Diabetologia. 2001;44:151–155
  16. Hankey GL, Holmes GK. Coeliac disease in the elderly. Gut. 1994;35:65–67
  17. Ivarsson A, Persson LA, Juto P, et al. High prevalence of undiagnosed coeliac disease in adults: a Swedish population-based study. J Intern Med. 1999;245:63–68
  18. Ravikumara M, Nootigattu VK, Sandhu BK. Ninety percent of celiac disease is being missed. J Pediatr Gastroenterol Nutr. 2007;45:497–499
  19. Vilppula A, Collin P, Maki M, et al. Undetected coeliac disease in the elderly: a biopsy-proven population-based study. Dig Liver Dis. 2008;40:809–813
  20. Dieterich W, Laag E, Schopper H, et al. Autoantibodies to tissue transglutaminase as predictors of celiac disease. Gastroenterology. 1998;115:1317–1321
  21. Sulkanen S, Halttunen T, Laurila K, et al. Tissue transglutaminase autoantibody enzyme-linked immunosorbent assay in detecting celiac disease. Gastroenterology. 1998;115:1322–1328
  22. Dieterich W, Laag E, Bruckner-Tuderman L, et al. Antibodies to tissue transglutaminase as serologic markers in patients with dermatitis herpetiformis. J Invest Dermatol. 1999;113:133–136
  23. Gomez JC, Selvaggio G, Pizarro B, et al. Value of a screening algorithm for celiac disease using tissue transglutaminase antibodies as first level in a population-based study. Am J Gastroenterol. 2002;97:2785–2790
  24. Tesei N, Sugai E, Vazquez H, et al. Antibodies to human recombinant tissue transglutaminase may detect coeliac disease patients undiagnosed by endomysial antibodies. Aliment Pharmacol Ther. 2003;17:1415–1423
  25. Hill PG, Forsyth JM, Semeraro D, et al. IgA antibodies to human tissue transglutaminase: audit of routine practice confirms high diagnostic accuracy. Scand J Gastroenterol. 2004;39:1078–1082
  26. Lock RJ, Stevens S, Pitcher MC, et al. Is immunoglobulin A anti-tissue transglutaminase antibody a reliable serological marker of coeliac disease?. Eur J Gastroenterol Hepatol. 2004;16:467–470
  27. Collin P, Kaukinen K, Vogelsang H, et al. Antiendomysial and antihuman recombinant tissue transglutaminase antibodies in the diagnosis of coeliac disease: a biopsy-proven European multicentre study. Eur J Gastroenterol Hepatol. 2005;17:85–91
  28. Bottaro G, Cataldo F, Rotolo N, et al. The clinical pattern of subclinical/silent celiac disease: an analysis on 1026 consecutive cases. Am J Gastroenterol. 1999;94:691–696
  29. Nuti R, Martini G, Valenti R, et al. Prevalence of undiagnosed coeliac syndrome in osteoporotic women. J Intern Med. 2001;250:361–366
  30. Howard MR, Turnbull AJ, Morley P, et al. A prospective study of the prevalence of undiagnosed coeliac disease in laboratory defined iron and folate deficiency. J Clin Pathol. 2002;55:754–757
  31. Rubio-Tapia A, Kyle RA, Kaplan EL, et al. Increased prevalence and mortality in undiagnosed celiac disease. Gastroenterology. 2009;137:88–93
  32. Metzger MH, Heier M, Maki M, et al. Mortality excess in individuals with elevated IgA anti-transglutaminase antibodies: the KORA/MONICA Augsburg cohort study 1989-1998. Eur J Epidemiol. 2006;21:359–365
  33. Lohi S, Maki M, Rissanen H, et al. Prognosis of unrecognized coeliac disease as regards mortality: a population-based cohort study. Ann Med. 2009;41:508–515
  34. Melton LJ. History of the Rochester Epidemiology Project. Mayo Clin Proc. 1996;71:266–274
  35. Kyle RA, Therneau TM, Rajkumar SV, et al. Prevalence of monoclonal gammopathy of undetermined significance. N Engl J Med. 2006;354:1362–1369
  36. Vilppula A, Kaukinen K, Luostarinen L, et al. Increasing prevalence and high incidence of celiac disease in elderly people: a population based study. BMC Gastroenterol. 2009;9:49
  37. Bergamaschi G, Markopoulos K, Albertini R, et al. Anemia of chronic disease and defective erythropoietin production in patients with celiac disease. Haematologica. 2008;93:1785–1791
  38. Fickling WE, McFarlane XA, Bhalla AK, et al. The clinical impact of metabolic bone disease in coeliac disease. Postgrad Med J. 2001;77:33–36
  39. Murray JA, Van Dyke C, Plevak MF, et al. Trends in the identification and clinical features of celiac disease in a North American community, 1950-2001. Clin Gastroenterol Hepatol. 2003;1:19–27
  40. Collin P. Should adults be screened for celiac disease? (What are the benefits and harms of screening?). Gastroenterology. 2005;128:S104–S108
  41. Fasano A. European and North American populations should be screened for coeliac disease. Gut. 2003;52:168–169
  42. Mearin ML, Ivarsson A, Dickey W. Coeliac disease: is it time for mass screening?. Best Pract Res Clin Gastroenterol. 2005;19:441–452
  43. Fabiani E, Taccari LM, Ratsch IM, et al. Compliance with gluten-free diet in adolescents with screening-detected celiac disease: a 5-year follow-up study. J Pediatr. 2000;136:841–843

 Conflicts of interest The authors disclose no conflicts.

 Funding This work was supported by research grants R01-DK57892, P01 CA62242, R01-AR30582, and T-32 AI07047 (A.R.-T.) from the National Institutes of Health, U.S. Public Health Service. The project described was supported by grant number 1 UL1 RR024150 from the National Center for Research Resources, a component of the National Institutes of Health, and the National Institutes of Health Roadmap for Medical Research. Its contents are solely the responsibility of the authors and do not necessarily represent the official view of the National Center for Research Resources or the National Institutes of Health. Information on the National Center for Research Resources is available at http://www.ncrr.nih.gov/. Information on Reengineering the Clinical Research Enterprise can be obtained from http://nihroadmap.nih.gov.

PII: S0016-5085(10)00802-4

doi: 10.1053/j.gastro.2010.05.041

Gastroenterology
Volume 139, Issue 3 , Pages 763-769 , September 2010

Article Tools

* Image Usage & Resolution